a subsidiary company of Laurus Labs. The company completed the said transaction on December 20. The Competition Commission of ...

Catch up on the latest stock market news! Today, we cover key developments including Aurobindo Pharma’s marketing authorization for its biosimilar, Fortis Healthcare's stake acquisition in Agilus ...

Indian stock market is expected to maintain its upward momentum, targeting Nifty 50 at 28,700 level. However, this upward ...

J B Chemicals & Pharmaceuticals Ltd.(down 1.8 per cent), Torrent Pharmaceuticals Ltd.(down 0.57 per cent), Ajanta Pharma Ltd.

AM(IST)on Tuesday in an upbeat market. Granules India Ltd.(up 2.98 per cent), Biocon Ltd.(up 1.87 per cent), Gland Pharma Ltd ...

"The stock has decisively broken out of a 'Falling Channel' pattern at Rs 823 level on weekly charts with a strong bullish candle, signalling a continuation of the medium-term uptrend. The stock ...

Stocks including UltraTech Cement, Reliance Industries, Tata Consultancy Services, NTPC Green, Indian Oil, Aurobindo Pharma, ...

Laurus Labs announced that its subsidiary, Laurus Bio, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital.

Market expert Aamar Singh analyzes the current market situation. Nifty's pullback is expected, but further selling pressure ...

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs ...

IST, the barometer index, the S&P BSE Sensex, was up 116.66 points or 0.15% to 78,656.22. The Nifty 50 index added 32.75 points or 0.14% to 23,786.20.